Avicanna Inc. (T:AVCN)

Business Focus: Biotechnology & Medical Research (NEC)

Get the company report for the most recent outlook updated daily

Apr 18, 2024 05:00 pm ET

Avicanna Announces Closing of Non-brokered Private Placement

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that...

Apr 10, 2024 08:37 am ET

Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study

Apr 02, 2024 07:30 am ET

Avicanna Reports Full Year 2023 Audited Financial Results

Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year...

Mar 27, 2024 08:02 am ET

Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation

Mar 26, 2024 07:30 am ET

Avicanna To Hold Full Year 2023 Earnings Conference Call

Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, invites interested parties to...

Mar 25, 2024 07:00 am ET

ThreeD Capital Inc. Announces New YouTube Channel

ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is excited to announce its...

Feb 29, 2024 07:30 am ET

Avicanna Hosts Symposium on Cannabinoid-based Medicine

Feb 15, 2024 07:30 am ET

Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company

Feb 13, 2024 07:30 am ET

Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™

Feb 05, 2024 07:50 am ET

Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company

Jan 30, 2024 07:30 am ET

Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil

Dec 04, 2023 05:00 pm ET

Avicanna Announces Closing of Non-Brokered Private Placement

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the development advancement, and commercialization of evidence-based, cannabinoid-based...

Nov 14, 2023 05:00 pm ET

Avicanna Reports Q3 2023 Results

Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and medical cannabis care platform is pleased to announce the...

Nov 13, 2023 05:30 pm ET

Avicanna Announces Appointment of Paul Fornazzari to Board of Directors

Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and a medical cannabis care platform is pleased to announce the...

Nov 01, 2023 05:55 pm ET

Avicanna To Hold Third Quarter 2023 Earnings Conference Call

Oct 11, 2023 07:30 am ET

Avicanna Provides Update on the Successful Launch of MyMedi.ca

Sep 01, 2023 05:30 pm ET

Retirement of Chandra Panchal, PhD from the Board of Directors

Aug 15, 2023 07:30 am ET

Avicanna Reports Q2 2023 Financial Statement

Avicanna Inc. (“Avicanna” or “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased announce the filing...

Aug 02, 2023 07:50 pm ET

Avicanna Announces Closing of Non-Brokered Private Placement of Debenture Units

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial stage, and international biopharmaceutical company focused on the development advancement, and commercialization of evidence-based,...

Aug 01, 2023 07:30 am ET

Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca

Jul 28, 2023 07:30 am ET

Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca Platform

Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is pleased to announce its...

Jul 17, 2023 07:30 am ET

Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay

Jun 28, 2023 07:30 am ET

Avicanna Provides Corporate Update and Preliminary Q2 Results

Jun 26, 2023 07:30 am ET

Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna’s Proprietary SEDDS Technology Capsules for Canadian and International markets

Jun 22, 2023 07:30 am ET

Avicanna Sponsors New Medical Cannabis Education and Training Campaign in Canada with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”)

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce...

Jun 13, 2023 07:30 am ET

Avicanna and Langara College Announce Cannabinoid-Based Translational Research Collaboration and NSERC Grant

May 29, 2023 07:30 am ET

Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business

Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the...

May 17, 2023 05:30 pm ET

Avicanna Announces Results of Annual General and Special Meeting and Provides Corporate Update

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the development, ‎advancement, and commercialization of evidence-based, cannabinoid-based...

May 16, 2023 07:30 am ET

Avicanna Reports Q1 2023 Financial Statement

Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased announce the...

May 04, 2023 07:30 am ET

Avicanna and Northern Green Canada Execute Master Service Agreement to Operationalize MyMedi.ca

Apr 03, 2023 07:30 am ET

Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2022

Mar 28, 2023 07:50 am ET

Shoppers Drug Mart partners with Avicanna to transition Medical Cannabis by Shoppers

Mar 21, 2023 07:30 am ET

Avicanna Announces Closing of Non-Brokered Private Placement

Feb 07, 2023 10:14 am ET

Avicanna completes first international export of cannabis seeds between Colombia and Spain

Avicanna CEO Aras Azadian joined Proactive's Natalie Stoberman to discuss the completion of its first export of feminized cannabis seeds to Spain.

Feb 07, 2023 07:43 am ET

Avicanna Expands its Partnership with Viola Brands to the United Kingdom

Feb 03, 2023 10:02 am ET

Avicanna says 2022 was transformational despite challenging cannabis market

Avicanna Inc CEO Aras Azadian joined Proactive's Natalie Stoberman with the company's Year in Review including milestones reached in 2022.

Jan 30, 2023 05:00 pm ET

Avicanna Announces Warrant and Debenture Repricing and Amendments

Jan 17, 2023 07:30 am ET

Avicanna Subsidiary Santa Marta Golden Hemp S.A.S. Completes First Commercial Export of feminized Cannabis Seeds from Colombia to Spain

Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that,...

Dec 30, 2022 07:30 am ET

Avicanna Announces Organizational Change in Avicanna LATAM S.A.S

Dec 21, 2022 05:00 pm ET

Avicanna Announces Promotion of Phillip Cardella to Chief Financial Officer and Closing of Non-Brokered Private Placement

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial-stage, international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based, cannabinoid-based...

Dec 14, 2022 07:33 am ET

Avicanna and Santé Cannabis Initiate Real-World Evidence Study on Musculoskeletal Pain and Inflammation with the RHO Phyto™ CBG Transdermal Gel Topical Product

Nov 29, 2022 07:30 am ET

Avicanna Commercializes ‘Influid’, a Proprietary Water-soluble technology in the Canadian Market

Nov 14, 2022 07:30 am ET

Avicanna Reports Q3 2022 Financial Statement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, November 14, 2022 (GLOBE NEWSWIRE)...

Nov 11, 2022 07:30 am ET

Avicanna Announces Closing of Non-Brokered Private Placement

Oct 31, 2022 05:00 pm ET

Avicanna Announces Extension of Term Loan

Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid based products, announces that it has...

Oct 20, 2022 07:30 am ET

Avicanna Files Complete Patent Specifications Relating to a Novel Cannabinoid Formulation for Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy

Oct 18, 2022 07:30 am ET

Avicanna Introduces a New Medical Cannabis Education Online Portal, “Avicenna Academy” for Health Care Professionals

Sep 15, 2022 09:08 am ET

Avicanna Expands its Epilepsy Research Program with a New Collaboration with the University of Toronto

Sep 01, 2022 07:30 am ET

Avicanna Announces Results of Annual General and Special Meeting

Aug 17, 2022 05:00 pm ET

Avicanna Announces Closing of Strategic Private Placement

Aug 15, 2022 05:00 pm ET

Avicanna Reports Q2 2022 Financial Statement

Jul 20, 2022 07:30 am ET

Avicanna and Ei. Ventures Enter into an Agreement to Develop and Commercialize Adaptogen Nutraceuticals

Avicanna Inc. ("Avicanna" or the "Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that...

Jul 11, 2022 05:15 pm ET

Avicanna Announces Date of Upcoming Annual General and Special Meeting of Shareholders

Avicanna Inc. ("Avicanna" or the "Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that...

Jul 07, 2022 07:30 am ET

Avicanna Completes its First Commercial Export of its Derma-Cosmetics Brand Pura H&W™ into the European Union

Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that...

Jun 24, 2022 07:30 am ET

Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

Jun 21, 2022 07:00 am ET

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 33rd Emerging Growth Conference. The Emerging...

Jun 09, 2022 07:30 am ET

Avicanna’s Subsidiary Santa Marta Golden Hemp Completes First Commercial Export of Feminized Cannabis Seeds to Lesotho

May 24, 2022 07:30 am ET

Avicanna Subsidiary Santa Marta Golden Hemp S.A.S. Completes First Commercial Export of Aureus™ Branded THC and CBD Extracts to Portugal

May 12, 2022 09:00 pm ET

Avicanna Reports Q1 2022 Financial Statement and Management Change

May 09, 2022 08:30 am ET

Mycotopia Therapies Inc. Update on Ei.Ventures and Strategic Investments

Mycotopia Therapies Inc. (OTC Pink: TPIA), a biopharma company focused on research, technology, and the development of medical psychedelics, and Ei.Ventures Inc., a technology company empowering mental wellness through psychoactive compounds,...

May 06, 2022 05:00 pm ET

Avicanna Announces Closing of Strategic Private Placement

Apr 28, 2022 07:30 am ET

Avicanna Expands RHO PhytoTM Formulary with the Introduction of Cannabigerol (CBG) Products into the Canadian Market

Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that...

Apr 13, 2022 07:00 am ET

Avicanna Enters into Exclusive License and Supply Agreement with Major South American Pharmaceutical Company

Avicanna Inc. ("Avicanna" or the "Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development and commercialization of plant-derived medical and pharmaceutical cannabinoid-based products, is pleased to...

Apr 05, 2022 07:30 am ET

Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG

Mar 31, 2022 08:46 pm ET

Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021

Mar 31, 2022 05:00 pm ET

Avicanna Announces Closing of Non-Brokered Private Placement

Feb 14, 2022 07:30 am ET

Avicanna Enters into a Strategic Partnership with Tetra Bio-Pharma

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based,...

Feb 02, 2022 07:30 am ET

Avicanna Provides Q4-2021 Results and Corporate Highlights as well as Fiscal 2022 Guidance

Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based,...

Jan 28, 2022 05:00 pm ET

Avicanna Announces Closing of Non-Brokered Private Placement of Convertible Debenture Units

Jan 14, 2022 07:30 am ET

Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.

Jan 10, 2022 07:30 am ET

Avicanna Announces the Appointment of Stephen Kim as Chief Legal Officer & General Counsel

Avicanna USA Inc. together with Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of organic and sustainable plant-derived...

Jan 04, 2022 07:30 am ET

Avicanna Announces Changes to its Board of Directors

Dec 24, 2021 07:30 am ET

Avicanna Completes First Commercial Export of CBG Into the European Union

Dec 22, 2021 07:30 am ET

Avicanna Launches its Clinically Backed CBD Derma-cosmetics Brand, Pura H&W, in the United States in Partnership with Red White and Bloom

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based pharmaceuticals, is pleased to...

Dec 20, 2021 07:30 am ET

Avicanna and Harrington Wellness launch re+PLAY™ branded CBD topicals products in Canada

Dec 10, 2021 07:30 am ET

Avicanna to Participate in the Lytham Partners Winter 2021 Investor Conference

Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announced today it will be...

Dec 06, 2021 07:30 am ET

Avicanna Files a Patent to Protect its Advanced Oral Cannabinoid Platform and its Applications for Neurological Diseases

Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based pharmaceuticals is pleased to announce...

Nov 30, 2021 07:30 am ET

Avicanna Enters into an Intellectual Property Licensing and Distribution Agreement with Established Pharmaceutical Company in Argentina

Nov 26, 2021 07:00 am ET

MediPharm Labs Completes Medical Cannabis Export to Barbados

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a medical cannabis export to Barbados in...

Nov 25, 2021 07:30 am ET

Avicanna Expands its Medical Cannabis Brand RHO Phyto into the Caribbean Region with Initial Export to Barbados

Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased to announce that...

Nov 12, 2021 07:30 am ET

Avicanna Announces Filing of Interim Financial Statements for the Three-Month Period Ending September 30, 2021, Demonstrating Progressive Commercialization Results

Nov 11, 2021 07:30 pm ET

Avicanna Announces Resignation of Director

Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of organic and sustainable plant-derived cannabinoid-based products...

Nov 09, 2021 07:30 am ET

Viola Brands Launches Nationwide in Canada through the Medical Cannabis by Shoppers™ online platform

Avicanna Inc. ("Avicanna" or the "Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a Canadian biopharmaceutical company focused on the development of plant-derived, cannabinoid-based products, announced today the distribution of Viola cannabis...

Nov 08, 2021 07:30 am ET

Avicanna Inc. to Host Third Quarter 2021 Investor Conference Call on November 12 and Announces Warrant Repricing

Nov 05, 2021 07:19 pm ET

Avicanna Announces Management Change

Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products...

Nov 04, 2021 07:30 am ET

Avicanna´s subsidiary obtains Good Agricultural and Collection Practices (“GACP”) Certification in Colombia

Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that...

Oct 22, 2021 07:30 am ET

Avicanna Completes Commercial Export of CBD Isolate and CBD Full Spectrum Psychoactive Derivatives from Colombia to Chile

Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that,...

Oct 19, 2021 05:15 pm ET

Avicanna Closes Non-Brokered Private Placement Raising $3.9 Million and Announces Warrant Repricing

Oct 01, 2021 07:30 am ET

Avicanna Completes First Commercial Export of Feminized Cannabis Seeds from Colombia to Peru and Argentina

Sep 24, 2021 07:30 am ET

Avicanna Files US Patent Application for a Novel Cannabinoid Formulation in Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy

Sep 20, 2021 08:35 am ET

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Life Sciences Investor Forum today announced that the presentations from the September 16th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live executive presentations and...

Sep 16, 2021 07:30 am ET

Avicanna Completes Registration and Commercial Export of its Evidence-Based CBD Dermacosmetics Brand, Pura Earth, in Ecuador

Sep 13, 2021 08:13 am ET

IIROC Trade Resumption - AVCN

TORONTO, Sept. 13, 2021 /CNW/ - Trading resumes in:

Sep 13, 2021 07:30 am ET

Avicanna Announces Revocation of Cease Trade Order

Sep 10, 2021 08:35 am ET

Life Sciences Virtual Investor Conference: Company Executives Present Live September 16th

Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations and...

Sep 10, 2021 07:30 am ET

Avicanna Announces Filing of Interim Financial Statements for Period Ended June 30, 2021 and Provides Corporate Update

Sep 07, 2021 10:50 pm ET

Avicanna Announces Filing of Interim Financial Statements For Three Month Period Ended March 31, 2021

Sep 03, 2021 11:32 pm ET

Avicanna Announces Filing of Annual Financial Statements For Year Ended December 31, 2020

Aug 27, 2021 07:30 am ET

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Aug 24, 2021 07:30 am ET

Avicanna Expands Sales of Pura Earth and RHO Phyto Branded Topicals into Alberta’s Retail Channels

Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that...

Aug 19, 2021 10:31 am ET

Avicanna Announces Closing of Secured Debt Financing

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) is pleased to announce closing of the previously announced secured term loan financing (the “Term Loan”) in the principal amount of $2,118,000. The Term Loan is subject to an original issue...

Aug 11, 2021 07:30 am ET

Avicanna Enters Partnership with Heritage Cannabis Holdings Corp. to Commercialize Evidence-Based Topical Products through Heritage’s Medical Cannabis Channels

Avicanna Inc. (“Avicanna'' or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that...

Aug 03, 2021 05:30 pm ET

Avicanna Announces Partial Revocation of Cease Trade Order and Proposed Financing

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announces that the Ontario Securities Commission ("OSC") has issued an order dated July 30, 2021 (the “Partial Revocation Order”) partially revoking the failure-to-file cease trade order...

Aug 03, 2021 07:30 am ET

Avicanna Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Peru

Jul 28, 2021 07:30 am ET

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Jul 16, 2021 05:25 pm ET

Avicanna Announces Change of Auditor

Jul 07, 2021 07:30 am ET

Avicanna Executes Multi Year Agreement to Supply Brazilian Pharmaceutical Company with THC and CBD Cannabis Extracts

Jun 30, 2021 06:56 pm ET

Avicanna Financial Statement Update

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announced today that the Company’s audit is ongoing and it expects to file the following periodic disclosure documents (collectively, the “Documents”) within the next sixty to seventy-five...

Jun 29, 2021 07:30 am ET

Avicanna and Bio-Gate Complete First Phase of Development on Cannabidiol (CBD) and MicroSilver BG™ Based Skin Care Products for Global Commercialization

Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that...

Jun 24, 2021 07:08 pm ET

Avicanna Announces Results of Annual General Meeting and Provides Corporate Update

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) is pleased to announce that all of management's nominees listed in the Company's management information circular dated May 25, 2021 were elected as directors of the...

Jun 15, 2021 07:30 am ET

Avicanna Expands The Canadian RHO Phyto Product Offerings With The Addition Of THC-Free High CBD Oral And Sublingual Formulation Across Medical And Adult Use Channels

Jun 14, 2021 08:07 am ET

IIROC Trading Halt - AVCN

TORONTO, June 14, 2021 /CNW/ - The following issues have been halted by IIROC:

Jun 11, 2021 08:29 pm ET

Cease Trade Order Issued by the Ontario Securities Commission

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announced today that it has been issued a Cease Trade Order (“CTO”) by the Ontario Securities Commission (the “OSC”) as it no longer expects to file the following periodic disclosure documents...

Jun 07, 2021 10:17 pm ET

Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) is providing this bi-weekly update on the status of the management cease trade order granted on April 12, 2021 (the “MCTO”) by its principal regulator, the Ontario Securities Commission under...

Jun 03, 2021 07:30 am ET

Avicanna Announces Mailing of Management Information Circular and Proposed Board Changes

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) is announcing that it has commenced mailing its management information circular (the “Information Circular”) and related proxy materials in relation to Avicanna’s annual general meeting of...

May 26, 2021 07:30 am ET

Avicanna’s Evidence-Based and Dermatologist Tested CBD Derma-Cosmetic Brand Pura Earth™ to be Launched in Adult-Use and Medical Channels Across Canada in Q2 2021

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that...

May 24, 2021 11:25 pm ET

Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order

May 10, 2021 06:00 pm ET

Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order

May 07, 2021 07:23 pm ET

Avicanna Announces Resignation of Board Member

May 06, 2021 07:30 am ET

Avicanna Makes RHO Phyto™ Medical Cannabis Products Available In Canadian Hospital Pharmacies Through Agreement with Sunnybrook Hospital

Apr 26, 2021 07:30 am ET

Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order

Apr 20, 2021 07:30 am ET

Avicanna Announces Initial Listings and Sales for Evidence-Based RHO Phyto™ Products in Canada’s Adult Use Channels Including Ontario, Manitoba, Saskatchewan, and New Brunswick

Apr 12, 2021 07:00 am ET

Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announces that, further to its March 29, 2021 news release, its application for a management cease trade order (the “MCTO”) under National Policy 12-203 – Management Cease ‎Trade Orders ("NP...

Mar 29, 2021 05:58 pm ET

Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order

Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announces that it will miss the deadline (the “Filing Deadline”) of March 31, 2021 to file the following (collectively, the “Documents”): the Company’s audited annual financial statements for...

Mar 29, 2021 07:30 am ET

Avicanna´s Majority Owned Colombian Subsidiary Attains 2021 THC Production Quota and Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Chile

Mar 25, 2021 07:30 am ET

Avicanna to Participate in Benzinga Biotech Small Cap Conference and the Virtual Life Sciences Investor Forum Both Taking Place on Thursday March 25th

Mar 23, 2021 07:30 am ET

Avicanna Enters Strategic Partnership with Al Harrington’s, Viola, for commercialization of Viola branded products in Canada

Mar 22, 2021 09:21 am ET

Avicanna Inc. to Webcast Live at Life Sciences Investor Forum March 25th

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, today announced that Aras Azadian, Chief Executive Officer,...

Mar 17, 2021 07:45 am ET

Avicanna to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

Mar 15, 2021 06:39 pm ET

NOTICE TO DISREGARD -- Avicanna Inc.

We are advised by Avicanna Inc. that journalists and other readers should disregard the news release, “Avicanna to present at the Q1 Virtual Investor Summit” issued March 11, 2021, over GlobeNewswire.

Mar 11, 2021 08:45 am ET

Avicanna to present at the Q1 Virtual Investor Summit

via InvestorWire- Avicanna (AVCNF) today announced that Aras Azadian, CEO, will be attending the Q1 Virtual Investor Summit. EventQ1 Investor Summit DateMarch 23-25th, 2021 PresentationMarch 24th @ 2:00PM...

Mar 04, 2021 01:22 pm ET

Avicanna Closes Non-Brokered Private Placement Raising $5.6 Million

Mar 04, 2021 01:07 pm ET

IIROC Trade Resumption - AVCN

TORONTO, March 4, 2021 /CNW/ - Trading resumes in:

Mar 04, 2021 01:01 pm ET

IIROC Trading Halt - AVCN

TORONTO, March 4, 2021 /CNW/ - The following issues have been halted by IIROC:

Feb 09, 2021 07:30 am ET

Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the United States

Jan 28, 2021 07:30 am ET

Avicanna Launches RHO Phyto™ Topical Gels in Canada and Initiates Clinical Studies

Jan 21, 2021 07:30 am ET

Avicanna Initiates Pre-Clinical and Behavioural Studies on its RHO Phyto™ Formulary with University of Guelph and Provides Research and Management Team Updates

Jan 13, 2021 01:15 pm ET

TMX Group, Avicanna, C-Suite at The Open

TORONTO, Jan. 13, 2021 /CNW/ - Aras Azadian, CEO, Avicanna Inc. (TSX: AVCN), shares his company's story in an interview with TMX Group.

Jan 06, 2021 07:30 am ET

Avicanna Advances Pharmaceutical Epilepsy Program With Collaboration With the University Health Network and GMP Manufacturing of its First Pharmaceutical Preparation

Dec 31, 2020 09:27 am ET

Avicanna Announces Exercise and Closing of Over-Allotment Option

Avicanna Inc. ("Avicanna", or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) is pleased to announce that further to the closing of its marketed public offering of 5,966,900 units (“Units”) of the Company at a price of $0.85 per Unit which...

Dec 23, 2020 07:30 am ET

Avicanna to Expand Access to Its Advanced and Evidence-Based RHO Phyto Medical Products Through Provincial Retailers Across Canada

Dec 21, 2020 08:35 am ET

Life Sciences Company Investor Presentations Now Available for On-Demand Viewing

Life Sciences Investor Forum today announced that the presentations from the December 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive...

Dec 17, 2020 07:30 am ET

Avicanna Expands Distribution Network in South America Through Commercial Partnerships in Ecuador and Commercial Export of Feminized Seeds to Uruguay

Dec 10, 2020 07:30 am ET

Avicanna Launches Medical Cannabis Program with its RHO Phyto™ Formulary Nationwide in Colombia

Dec 08, 2020 08:10 am ET

Avicanna Announces Closing of Public Offering of Units

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Nov 13, 2020 11:43 am ET

IIROC Trade Resumption - AVCN

TORONTO, Nov. 13, 2020 /CNW/ - Trading resumes in:

Nov 13, 2020 10:57 am ET

Avicanna Announces Pricing of Public Marketed Offering of Units

Nov 12, 2020 03:15 pm ET

Avicanna Announces Overnight Marketed Public Offering of Units

Nov 12, 2020 03:14 pm ET

IIROC Trading Halt - AVCN

TORONTO, Nov. 12, 2020 /CNW/ - The following issues have been halted by IIROC:

Nov 12, 2020 12:02 am ET

Avicanna Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Nov 02, 2020 06:29 pm ET

Avicanna Announces Closing of Non-Brokered Convertible Debenture Financing

Oct 20, 2020 06:40 pm ET

Avicanna Announces Results of Annual General and Special Meeting

Oct 12, 2020 08:35 am ET

Growth Company Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations

Oct 05, 2020 09:58 am ET

Live Growth Opportunities Investor Conference October 8th

Company executives will share vision and answer audience questions at VirtualInvestorConferences.com

Sep 29, 2020 07:45 am ET

Avicanna Enters Agreement to Develop and License Cannabinoid Tablet Formulations for US Distributor Partner

The agreement showcases Avicanna's expertise in cannabinoid product development and drug delivery across several delivery mechanisms

Sep 21, 2020 07:45 am ET

Avicanna's RHO Phyto™ Rapid Act Sprays are Now Available Nation Wide in Canada Through Medical Cannabis by Shoppers™

Sep 14, 2020 07:45 am ET

Avicanna's subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia

Sep 04, 2020 08:00 am ET

Avicanna Advances its Supply Chain Business and Announces Filing of Amended Interim Financial Statements

Aug 26, 2020 07:00 am ET

MediPharm Labs Launches New Sublingual Sprays for Sale via Medical Cannabis by Shoppers™ Under Agreement With Avicanna

MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its...

Aug 24, 2020 07:45 am ET

Avicanna Advances its Supply Chain Business with Commercial Exports of CBG And CBD into the United States and Germany as well as Industrial Scale THC Quota Granted by the Colombian Authorities

Aug 18, 2020 04:43 pm ET

Avicanna Closes Non-Brokered Private Placement Raising $2.7 Million

Aug 17, 2020 07:30 am ET

Avicanna Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Aug 12, 2020 07:45 am ET

Avicanna's RHO Phyto™ Medical Product Line is Now Available Nation-Wide in Canada Through Medical Cannabis by Shoppers Inc.™

RHO Phyto "Micro Drop" oil formulations are the first of the RHO Phyto formulary of advanced medical cannabis products available for patients and health care practitioners on the Medical Cannabis by Shoppers™ platform.

Aug 11, 2020 07:45 am ET

Avicanna and Red White & Bloom Enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States

The partnership allows for both companies to stake a claim in the expanding $532 billion beauty industry with the most advanced and only clinically backed CBD skin care line

Aug 07, 2020 06:11 pm ET

Avicanna Inc. to Host Second Quarter 2020 Investor Conference Call

Jul 24, 2020 07:45 am ET

Avicanna announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; an

In addition to a recent MITACS award, Dr. Christine Allen, a Professor at the University of Toronto, was awarded an NSERC Alliance grant for development of cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 induced lung inflammation

Jul 21, 2020 07:30 am ET

Pat McCutcheon, CEO of MediPharm Labs to Present at the Avicanna Hosted Virtual Symposium Titled "Medical Cannabis 2.0" in Partnership with Medical Cannabis by Shoppers™

Jul 15, 2020 07:45 am ET

Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Research Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers™ using its Rho

The Rho Phyto portfolio contains a full formulary of products including oil drops, sublingual sprays, capsules, and topicals that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data which will be available exclusively on the Medical Cannabis by Shoppers™ online portal by the end of July 2020.

Jul 10, 2020 08:35 am ET

Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations

Jul 10, 2020 08:35 am ET

Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing

NEW YORK, July 10, 2020 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the Cannabis & CBD Biopharma Virtual lnvestor Conference presentations are now available for on-demand viewing.

Jul 07, 2020 03:00 pm ET

Live Investor Conference & Webinar: Cannabis & CBD Biopharma Industry Companies Present July 9th

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

Jul 07, 2020 03:00 pm ET

Live Investor Conference & Webinar: Cannabis & CBD Biopharma Industry Companies Present July 9th

NEW YORK, July 7, 2020 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Cannabis & CBD Industry Virtual Investor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 10:15 AM ET, with the first live webcast at 10:30 AM ET, on Thursday, July 9th.

Jun 23, 2020 07:45 am ET

Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program

Avicanna further expands its existing research collaboration with Dr. Christine Allen's Research Group at the University of Toronto to include the development of a cannabinoid-based pharmaceutical for the treatment of COVID-19 induced lung inflammation

Jun 22, 2020 07:45 am ET

Avicanna to Host Virtual Symposium Titled "Medical Cannabis 2.0" on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers™ in Anticipation of the Launch of its Rho Phyto™ Product Line

- - -The symposium will present the evolution of medical cannabis including the Avicanna-led advancements in R&D for novel cannabinoid delivery forms and formulations in addition to enhanced access for patients by Medical Cannabis by Shoppers.

Jun 18, 2020 07:45 am ET

Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale

Seven million CBG dominant feminized seeds have been successfully exported to the US from Colombia and an additional seventy-five million seeds remain in inventory for sale to international markets.

Jun 09, 2020 07:45 am ET

Avicanna Successfully Registers the First Group of its Pura Earth™ CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization

May 26, 2020 12:06 am ET

Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update

May 14, 2020 10:14 pm ET

Avicanna to Postpone Reporting First Quarter 2020 Results Due to Delays Caused by COVID-19

May 14, 2020 06:35 am ET

MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.

May 14, 2020 06:35 am ET

Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs

May 07, 2020 07:45 am ET

Avicanna Receives Government Support and Approval for First Ever Export of Hemp Seeds From Colombia

Apr 21, 2020 07:45 am ET

Avicanna Closes Non-Brokered Private Placement with Group of Strategic Investors and Announces Warrant Re-Pricing

Apr 15, 2020 11:58 pm ET

Avicanna Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update

Mar 30, 2020 07:45 am ET

Avicanna to Postpone Reporting Fourth Quarter and Full Year 2019 Results Due to Delays Caused by COVID-19

Feb 24, 2020 06:45 am ET

Avicanna to Supply Australian Market with Cannabis-Based Medicinal Products Through Distribution Agreement with Cannvalate

Feb 06, 2020 06:45 am ET

Avicanna Ranks Highest Amongst Global Cannabis Companies in the SAM Corporate Sustainability Assessment (CSA)

Jan 24, 2020 04:30 pm ET

Avicanna Closes First Tranche of Private Placement

Jan 21, 2020 06:40 am ET

Avicanna Announces Appointment of Benjamin Leavenworth as Independent Director

Jan 13, 2020 06:40 am ET

Avicanna Announces the Successful Completion of its Clinical Study Evaluating the Effect of an Emollient Cream Containing 0.5% Cannabidiol on Skin Hydration

- - -Expects to present additional data from this study at future medical conferences and publications- - -This completed study is the first known completed derma-cosmetic study on cannabinoids - - -Plans to announce data from additional clinical studies of two other proprietary formulas used for Pura Earth products in Q1 2020

Jan 10, 2020 11:21 am ET

Avicanna Announces Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc., to Distribute Avicanna's Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Produc

Rho Phyto medical cannabis products and Pura Earth derma-cosmetics to be available exclusively in Canada online through Medical Cannabis by Shoppers in early-2020

Dec 27, 2019 06:45 am ET

Ad blocking detected

Avicanna Inc. (T:AVCN)

Business Focus: Biotechnology & Medical Research (NEC)